IBS AB håller årsstämma onsdagen den 20 juni 2012 kl. 10:00 i bolagets lokaler på Hemvärnsgatan 8 i Solna. Registrering och inpassering sker från och med kl. 09:30.
First North has sanctioned IBS AB:s application for delisting, with last trading day 31 August 2011.
IBS reports strong license revenue growth and increased productivity by focusing on core offerings, however restructuring costs, goodwill impairment and change in deferred tax items affect profitability.
IBS will issue financial information on the following dates:
Due to the concentrated shareholder structure in the company and taking into consideration the costs associated with being listed on a regulated market the IBS Board of Directors has resolved on applying for a listing of the IBS share on First North and with a simultaneous delisting of the share on Nasdaq OMX Small Cap.
IBS Annual Report for 2008 in English is now available at www.ibs.net.
IBS reports strong license revenue growth, and positive net earnings in the second quarter.